Literature DB >> 23065963

Thermodynamic and mechanistic insights into translesion DNA synthesis catalyzed by Y-family DNA polymerase across a bulky double-base lesion of an antitumor platinum drug.

Viktor Brabec1, Jaroslav Malina, Nicola Margiotta, Giovanni Natile, Jana Kasparkova.   

Abstract

To determine how the Y-family translesion DNA polymerase η (Polη) processes lesions remains fundamental to understanding the molecular origins of the mutagenic translesion bypass. We utilized model systems employing a DNA double-base lesion derived from 1,2-GG intrastrand cross-links of a new antitumor Pt(II) complex containing a bulky carrier ligand, namely [PtCl(2)(cis-1,4-dach)] (DACH=diaminocyclohexane). The catalytic efficiency of Polη for the insertion of correct dCTP, with respect to the other incorrect nucleotides, opposite the 1,2-GG cross-link was markedly reduced by the DACH carrier ligand. This reduced efficiency of Polη to incorporate the correct dCTP could be due to a more extensive DNA unstacking and deformation of the minor groove induced in the DNA by the cross-link of bulky [PtCl(2)(cis-1,4-dach)]. The major products of the bypass of this double-base lesion produced by [PtCl(2)(cis-1,4-dach)] by Polη resulted from misincorporation of dATP opposite the platinated G residues. The results of the present work support the thesis that this misincorporation could be due to sterical effects of the bulkier 1,4-DACH ligand hindering the formation of the Polη-DNA-incoming nucleotide complex. Calorimetric analysis suggested that thermodynamic factors may contribute to the forces that governed enhanced incorporation of the incorrect dATP by Polη as well.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065963     DOI: 10.1002/chem.201202117

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  6 in total

1.  Computational evidence for structural consequences of kiteplatin damage on DNA.

Authors:  Shaun T Mutter; Nicola Margiotta; Paride Papadia; James A Platts
Journal:  J Biol Inorg Chem       Date:  2014-11-07       Impact factor: 3.358

2.  Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration.

Authors:  Alessandra Barbanente; Valentina Gandin; Cecilia Ceresa; Cristina Marzano; Nicoletta Ditaranto; James D Hoeschele; Giovanni Natile; Fabio Arnesano; Concetta Pacifico; Francesco P Intini; Nicola Margiotta
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

3.  Cisplatin, Oxaliplatin, and Kiteplatin Subcellular Effects Compared in a Plant Model.

Authors:  Paride Papadia; Fabrizio Barozzi; James D Hoeschele; Gabriella Piro; Nicola Margiotta; Gian-Pietro Di Sansebastiano
Journal:  Int J Mol Sci       Date:  2017-01-31       Impact factor: 5.923

4.  A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring.

Authors:  Paride Papadia; Valentina Gandin; Alessandra Barbanente; Alessandro G Ruello; Cristina Marzano; Katia Micoli; James D Hoeschele; Giovanni Natile; Nicola Margiotta
Journal:  RSC Adv       Date:  2019-10-11       Impact factor: 3.361

5.  Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.

Authors:  Salvatore Savino; Cristina Marzano; Valentina Gandin; James D Hoeschele; Giovanni Natile; Nicola Margiotta
Journal:  Int J Mol Sci       Date:  2018-07-14       Impact factor: 5.923

6.  Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance.

Authors:  Paride Papadia; Katia Micoli; Alessandra Barbanente; Nicoletta Ditaranto; James D Hoeschele; Giovanni Natile; Cristina Marzano; Valentina Gandin; Nicola Margiotta
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.